OmniComm Systems Appoints Thomas Wells as Vice President of Technical Operations
Experienced industry veteran joins OmniComm’s executive team to drive technology operations for leading electronic data capture (EDC) company.
FT. Lauderdale, FL-June 2, 2008-OmniComm Systems, Inc., a leader in integrated electronic data capture (EDC) solutions for clinical trials, today announced that Thomas Wells has joined OmniComm to spearhead technology operations for the rapidly growing eClinical solutions company. Wells brings a strong pharmaceutical and health care background to the position. He will be responsible for driving strategy and delivering business processes and systems for product development as OmniComm delivers integrated solutions to meet industry demand.
Prior to joining OmniComm, Wells served as director, research and development informatics at Amgen, Inc. In his role at Amgen, he managed global teams that implemented and supported all of Amgen’s development systems. The teams implemented over 50 new clinical trials annually and maintained approximately 100+ trials in both EDC and Oracle Clinical. In addition, part of his responsibilities included expanding the global EDC program into large Phase II and III clinical trials. Prior to Wells’ tenure at Amgen, he worked for Integrium, a clinical research organization, as director, information technology where he developed and implemented all clinical trials management systems and all data management systems to fully integrate and interface with OCR, EDC, and other external sources. He also partnered with QA and was responsible for all sponsor audits.
Before joining Integrium, Wells served as senior systems architect for Ultralink Inc., a Web-based health care system and EDI solutions company. Prior to that, he held positions with Cocensys, Inc, a CNS biopharmaceutical company, Specialized Clinical Services, Inc., Long Beach Genetics, Inc., and Eastman Kodak, Clinical Products Division.
“Thomas’s exceptional industry credentials are a welcome addition to the OmniComm team and we look forward to benefiting from his strategic vision for technical operations," said Cornelis F. Wit, chief executive officer for OmniComm. “He brings a plethora of industry knowledge and experience that will help OmniComm bring to fruition the next generation eClinical products and solutions that our clients demand.”
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Ifinatamab Deruxtecan Shows High Response Rates for Heavily Pretreated Small Cell Lung Cancer
September 9th 2024Potential first-in-class B7-H3 directed antibody drug conjugate ifinatamab deruxtecan shows potential to improve outcomes for patients living with difficult-to-treat form of lung cancer.
